Assist
Where required, assists with the provision of analytical services, also ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Act.
Learn MoreThe Content of this website is for MATURE audiences only.
By continuing to view the website you are claiming that you are 18 years or older.
Call: +1 (246) 421-4141 | Email: clo@bmcla.bb
Where required, assists with the provision of analytical services, also ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Act.
Learn MoreDevelop policies, procedures and guidelines to establish the medicinal cannabis industry and to ensure that medicinal cannabis is available to patients in a safe and efficient manner.
Learn MoreIssues licences in relation to the handling of medicinal cannabis in accordance with the provisions of the Act, 2019, also provides for the distribution of educational materials etc.
Learn MoreRegulates the handling of medicinal cannabis, with the approval of the Barbados Medicinal Cannabis Licensing Board, establishes and maintains an electronic database.
Learn MoreThere are two major concerns regarding smoking medicinal cannabis.
Firstly, smoking is a particularly harmful way of taking medicinal cannabis, mainly because it poses comparable risks for bronchitis and lung cancer, as is the smoking of cigarettes. Smoking medicinal cannabis is not permitted by local or international Health authorities.
Secondly, approved medicines used in Barbados are produced under strict conditions to ensure efficacy and safety. It is important that medical doctors know that medicines have been tested and are standardized by dose and therapeutic response. This means doctors can monitor the effects of the drug and doses can be adjusted according to a patient’s needs.
It is understood that smoked cannabis will not be prescribed in Barbados because smoked plant products will not satisfy governmental requirements.
Cannabidiol (CBD) is one of the bioactive compounds and naturally occurring cannabinoids in the cannabis plant. It is one of the most medically relevant chemical compounds found in the cannabis plant, but it’s different from THC because of its opposing antagonistic effect compared to THC. It is also not as psychoactive as THC and is noted more for its medicinal effects.
There is really no difference between the terms of adult use and recreational use of cannabis. However, the term “adult-use” while is for better optics, it comes from the notion that not all consumers of cannabis are consuming solely for recreational purposes. Cannabis can and is utilized for many reasons that go beyond the recreational/ medicinal cannabis binary.
The Barbados Medicinal Cannabis Licensing Authority (BMCLA) is the sole regulator, that is mandated to create and position the local medicinal cannabis industry as a global centre of excellence in training, certification, research and development and to provide a high quality, accessible and advanced patient-centric environment to qualifying individuals.
The BMCLA also ensures that the safety of the public and consumers of medicinal cannabis and its by-products are adequately protected, by appropriately regulating the importation, sale, distribution, possession, purchase, manufacture, cultivation, transportation and exportation of medicinal cannabis.
Medicinal Cannabis is cannabis that is grown and sold pursuant to the Medicinal Cannabis Industry Act, 2019 that includes the seeds, immature plants as well as all parts of the plant, along with resin extracted from any part of the plant, every compound, manufacture, salt, derivative, mixture or preparation from cannabis; or cannabis concentrate; that is cultivated, processed, manufactured, distributed or sold under a licence from the BMCLA. As a medicine, it is prescribed and recommended by physicians to provide a therapeutic effect.
16. Can a minor be prescribed medicinal cannabis?
According to the Barbados Medicinal Cannabis Industry Act, 2019 the parent or guardian of a patient who is a minor shall obtain a certificate in writing from a medical practitioner certifying that the use of medicinal cannabis is necessary in the case of that minor, and the parent or guardian shall consent in writing to the use of medicinal cannabis for the treatment of the minor.
The Act also states that a parent or legal guardian of a patient who is a minor shall be deemed to be the caregiver for that minor unless that parent or legal guardian designates another person, or a person is designated by an order of the Court.
Any person who is under the age of 18 years shall not be designated as a caregiver.
17. How will sale of medicinal cannabis to minors be addressed, particularly in light of those studies that suggest adolescents and pre-adolescents are more susceptible to negative psychological and medical consequences from using cannabis?
There will be no sale of medicinal cannabis to minors. Possession of cannabis on or near school premises, the inclusion of a child or young person in the drug trade and the purchase of cannabis from a child or young person is illegal and on indictment could result in imprisonment for life (Drug Abuse (Prevention and Control) Act Chapter 131).
A parent or guardian of a patient who is a minor or young person can access medicinal cannabis via mechanisms described above. However, a person who is under the age of 18 years shall not be designated as a caregiver of a minor or young person.
Important Note:Cannabis affects the same biological system in the brain that is responsible for brain development. The earlier you start consuming cannabis, the more harm it can do. Starting as a teen, consuming frequently (daily or near daily) and over a long time (several months or years) increases the risk of mental health problems. These problems include dependence and disorders related to psychosis, anxiety and depression. [1] For more information, visit your doctor.
[1] Chadwick B, Miller ML, Hurd YL. Cannabis use during adolescent development: Susceptibility to psychiatric illness. Front Psychiatry 2013 Oct 14;4:129.